Exhibit 99.7
May 24, 2017
OncoGenex Pharmaceuticals, Inc.
19820 North Creek Parkway
Bothell, Washington 98011
Consent to Reference in Proxy Statement/Prospectus/Information Statement
OncoGenex Pharmaceuticals, Inc. (the “Company”) is filing a Registration Statement on FormS-4 (RegistrationNo. 333-216961) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus/information statement included in such registration statement as a future member of the board of directors of the Company.
Sincerely,
/s/ Donald Joseph |
| Name: Donald Joseph |
